Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease

Abstract

Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra, causing motor changes. In addition to motor symptoms, non-motor dysfunctions such as psychological, sensory and autonomic disorders are recorded. Manifestations related to the autonomic nervous system include the cardiovascular system, as postural hypotension, postprandial hypotension, and low blood pressure. One of the mediators involved is the nitric oxide (NO). In addition to the known roles such as vasodilator, neuromodulator, NO acts as an important mediator of the immune response, increasing the inflammatory response provoked by PD in central nervous system. The use of non-specific NOS inhibitors attenuated the neurodegenerative response in animal models of PD. However, the mechanisms by which NO contributes to neurodegeneration are still not well understood. The literature suggest that the contribution of NO occurs through its interaction with superoxides, products of oxidative stress, and blocking of the mitochondrial respiratory chain, resulting in neuronal death. Most studies involving Parkinsonism models have evaluated brain NO concentrations, with little data available on its peripheral action. Considering that studies that evaluated the involvement of NO in the neurodegeneration in PD, through NOS inhibitors administration, showed neuroprotection in rats, it has prompted new studies to assess the participation of NOS isoforms in cardiovascular changes induced by parkinsonism, and thus to envision new targets for the treatment of cardiovascular disorders in PD. The aim of this study was to conduct a literature review to assess available information on the involvement of nitric oxide (NO) in cardiovascular aspects of PD.

Recent advances in DDAH1 inhibitor design and discovery: insights from structure–activity relationships and X-ray crystal structures

“…Nitric oxide synthase (NOS) is the enzyme responsible for NO synthesis. Excessive NO production is associated with a wide range of pathophysiological states including multiple sclerosis, 4 sepsis, 5 Parkinson's disease, 6 metabolic dysregulation, 7 and cancer. 8 The use of NOS inhibitors may directly inhibit NO production, however, simultaneously blocking its beneficial effects.…”

A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory

“…However, they have their own unique symptoms. For example, AD is mainly manifested by sensory memory decline and progressive loss of cognitive function [ 6 ], while PD is mainly manifested by sensory motor loss [ 7 ].…”

Microarrays, Enzymatic Assays, and MALDI-MS for Determining Specific Alterations to Mitochondrial Electron Transport Chain Activity, ROS Formation, and Lipid Composition in a Monkey Model of Parkinson’s Disease

“…NO can lead to the formation of peroxynitrite (ONOO − ), which produces the interaction of NO with superoxide radicals [ 31 , 32 ]. NO can also inhibit the mitochondrial respiratory chain, especially in complex IV [ 33 ].…”